Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 13, 2013
[ Wed, Mar 13th 2013
] - WealthMakers
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WealthMakers
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - Market Wire
[ Wed, Mar 13th 2013
] - Market Wire
[ Wed, Mar 13th 2013
] - Market Wire
[ Wed, Mar 13th 2013
] - Market Wire
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
[ Wed, Mar 13th 2013
] - WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $14 on, Mar 13th, 2013
Michael Wiederhorn of Oppenheimer, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $15 to $14 on, Mar 13th, 2013.
Michael has made no other calls on AMED in the last 4 months.
There is 1 other peer that has a rating on AMED. Out of the 1 peers that are also analyzing AMED, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- John Ransom of "Raymond James" Downgraded from Hold to Sell on, Thursday, February 21st, 2013
